Search results
Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Insider Monkey via Yahoo Finance UK· 4 days agoWe recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 6 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
FDA approves second Alzheimer’s drug that can modestly slow disease
Express and Star· 2 days agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab,...
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 3 days agoThe US FDA has approved donanemab, a treatment for Alzheimer's disease that helps the body remove...
Weight-loss drugs linked with lower risk of obesity-related cancers
Gulf News· 3 hours agoBlockbuster weight loss and diabetes drugs may lower patients' risk of developing some common types...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News UK· 2 days agoDonanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the...
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimer's drug
Reuters· 2 days agoEli Lilly's Kisunla secured standard approval from the U.S. Food and Drug Administration on Tuesday...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 3 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
How Jeremy Hunt survived the breaking of the Blue Wall
The New Statesman· 4 hours ago“This is the Holy Grail,” one Lib Dem told me as we sat waiting for the count in Godalming and Ash....
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024
Associated Press Finance via Yahoo Finance UK· 3 days agoDigital-media conglomerate IAC is reportedly considering a bid to take control of the owner of CBS and Paramount Studio. Eli Lilly and Co., down $7.66 to ...